Tracking the mechanism of fibril assembly by simulated two-dimensional ultraviolet spectroscopy
- PMID: 23214934
- PMCID: PMC3684205
- DOI: 10.1021/jp3101267
Tracking the mechanism of fibril assembly by simulated two-dimensional ultraviolet spectroscopy
Abstract
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the accumulation of plaque deposits in the human brain. The main component of these plaques consists of highly ordered structures called amyloid fibrils, formed by the amyloid β-peptide (Aβ). The mechanism connecting Aβ and AD is yet undetermined. In a previous study, a coarse-grained united-residue model and molecular dynamics simulations were used to model the growth mechanism of Aβ amyloid fibrils. On the basis of these simulations, a dock/lock mechanism was proposed, in which Aβ fibrils grow by adding monomers at either end of an amyloid fibril template. To examine the structures in the early time-scale formation and growth of amyloid fibrils, simulated two-dimensional ultraviolet spectroscopy is used. These early structures are monitored in the far ultraviolet regime (λ = 190-250 nm) in which the computed signals originate from the backbone nπ* and ππ* transitions. These signals show distinct cross-peak patterns that can be used, in combination with molecular dynamics, to monitor local dynamics and conformational changes in the secondary structure of Aβ-peptides. The protein geometry-correlated chiral xxxy signal and the non-chiral combined signal xyxy-xyyx were found to be sensitive to, and in agreement with, a dock/lock pathway.
Conflict of interest statement
The authors declare no competing financial interest
Figures





Similar articles
-
Distinguishing amyloid fibril structures in Alzheimer's disease (AD) by two-dimensional ultraviolet (2DUV) spectroscopy.Biochemistry. 2011 Nov 15;50(45):9809-16. doi: 10.1021/bi201317c. Epub 2011 Oct 20. Biochemistry. 2011. PMID: 21961527 Free PMC article.
-
Phosphorylation at Ser8 as an Intrinsic Regulatory Switch to Regulate the Morphologies and Structures of Alzheimer's 40-residue β-Amyloid (Aβ40) Fibrils.J Biol Chem. 2017 Feb 17;292(7):2611-2623. doi: 10.1074/jbc.M116.757179. Epub 2016 Dec 28. J Biol Chem. 2017. PMID: 28031462 Free PMC article.
-
Simulation of two-dimensional ultraviolet spectroscopy of amyloid fibrils.J Phys Chem B. 2010 Sep 23;114(37):12150-6. doi: 10.1021/jp1046968. J Phys Chem B. 2010. PMID: 20795695 Free PMC article.
-
Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.Acc Chem Res. 2014 Feb 18;47(2):603-11. doi: 10.1021/ar4002075. Epub 2013 Dec 24. Acc Chem Res. 2014. PMID: 24368046 Review.
-
Structural polymorphism of Alzheimer Abeta and other amyloid fibrils.Prion. 2009 Apr-Jun;3(2):89-93. doi: 10.4161/pri.3.2.8859. Prion. 2009. PMID: 19597329 Free PMC article. Review.
Cited by
-
Probing Protein Aggregation Using the Coarse-Grained UNRES Force Field.Methods Mol Biol. 2022;2340:79-104. doi: 10.1007/978-1-0716-1546-1_5. Methods Mol Biol. 2022. PMID: 35167071
-
Fibril elongation by Aβ(17-42): kinetic network analysis of hybrid-resolution molecular dynamics simulations.J Am Chem Soc. 2014 Sep 3;136(35):12450-60. doi: 10.1021/ja507002p. Epub 2014 Aug 25. J Am Chem Soc. 2014. PMID: 25134066 Free PMC article.
-
Elucidating Important Sites and the Mechanism for Amyloid Fibril Formation by Coarse-Grained Molecular Dynamics.ACS Chem Neurosci. 2017 Jan 18;8(1):201-209. doi: 10.1021/acschemneuro.6b00331. Epub 2016 Nov 18. ACS Chem Neurosci. 2017. PMID: 28095675 Free PMC article.
-
Protein misfolding and aggregation in Alzheimer's disease and type 2 diabetes mellitus.CNS Neurol Disord Drug Targets. 2014;13(7):1280-93. doi: 10.2174/1871527313666140917095514. CNS Neurol Disord Drug Targets. 2014. PMID: 25230234 Free PMC article.
-
My 65 years in protein chemistry.Q Rev Biophys. 2015 May;48(2):117-77. doi: 10.1017/S0033583514000134. Epub 2015 Apr 8. Q Rev Biophys. 2015. PMID: 25850343 Free PMC article. Review.
References
-
- Lorenzo A, Yuan M, Zhang Z, Paganetti PA, Sturchler-Pierrat C, Staufenbiel M, Mautino J, Vigo FS, Sommer B, Yankner BA. Nature Neurosci. 2000;3:460–464. - PubMed
-
- Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwy R, Wolfe MS, Rowan MJ, Selkoe DJ. Nature. 2002;416:535–539. - PubMed
-
- Selkoe DJ. Physio Rev. 2001;81:741–766. - PubMed
-
- Kirkitadze MD, Bitan G, Teplow DBJ. Neurosci Res. 2002;69:567–577. - PubMed
-
- Hardy J, Selkoe DJ. Science. 2002;297:353–356. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical